Insights into the evolution of virulence may aid efforts to control or even prevent emerging diseases. Specifically, dangerous pathogens can be distinguished from those that pose relatively little threat by identifying characteristics that favor intense exploitation of hosts by pathogens, hence causing high virulence. Studies to date have implicated several such characteristics, including transmission by vectors, attendants, water, and durable propagules. These insights may improve the return on investments in disease control by directing effort and resources to the most-dangerous emerging pathogens. The approach also should help us to identify those control measures that will guard against the future emergence of dangerous pathogens, even those that have not yet been identified.
organisms can cause serious disease in humans, pessimists may say that this goal is hopeless. Optimists may say that it can be done if only we invest sufficient resources. I am pessimistically optimistic. I think that controlling the emergence of some kinds of disease organisms is virtually hopeless; however, we should be able to control some of the most-serious threats if we broaden our perspective to understand better the reasons why serious disease has occurred so commonly in the past. We then should be able to apply this understanding to enact policies that will allow us to recognize the major threats and focus on the subsets of these threats for which our efforts can be productive.
Even this more-modest goal will be challenging, but integration of insights from evolutionary biology can help us substantially in whittling down a seemingly overwhelming challenge into a more manageable one. Our greatest concern is with those disease organisms that are likely to be stably virulent in the human *Dr. Ewald population over time. In using the term stably virulent, I refer to the number of people who will be affected negatively integrated over the duration of time during which an emergent disease will persist in the human population. The components of this concern are the harmfulness per infection, the prevalence of infection, and the persistence of this prevalence. A flare-up of a highly lethal disease in a few hundred people is not as much of a threat as the inexorable smoldering of a moderately lethal organism that can persist indefinitely, albeit less dramatically. The tuberculosis bacterium, in the broader analysis, is more dangerous to humans than the Ebola virus, even though Ebola in the hands of the media may make for a more sensational script.
FUNDAMENTAL QUESTIONS
This perspective on emerging diseases raises a critical question: Why do some disease organisms evolve toward a high, often lethal, virulence, whereas others, like the common cold virus, do not kill anyone, not even those who have compromised immune systems? There are two ways of approaching this question. The conventional approach is to try to understand the biochemical mechanisms that make one disease organism more severe than another. According to this conventional approach, one would say that the bacterium that causes cholera is often virulent because it produces a large amount of toxin, which in turn causes a large amount of fluid to rush into the lumen of the intestine from the cells that line the intestine. This fluid loss causes reduced blood volume, which then can cause shock and death. In evolutionary biology, such explanations are referred to as "proximate explanations" because they deal with the immediate mechanisms that cause the phenomenon. They comprise a perfectly valid and important class of explanations. For each proximate explanation in biology, however, there also exists a complementary "ultimate explanation," which considers why the characteristic has evolved. An ultimate explanation for cholera's virulence would consider how those organisms that produced a high amount of toxin might be superior competitively to those that produce less toxin. Such ultimate explanations of virulence thus focus on why organisms that possess a given level of virulence persist through time, even though other competing organisms with a different level of virulence presumably are being generated continually by mutations.
Having made this key distinction, we can ask a general ultimate question:
Why are some disease organisms severe, while others are benign? We ask this question with the expectation that the answer will allow us to identify particular pathogens that confront us with the gravest long-term threat: pathogens that, if they get into the human population, may persist in a damaging state for a long period of time, pathogens like malaria, tuberculosis, and cholera.
EVOLUTIONARY

MECHANISMS OF EMERGING INFECTIONS
Ren6 Dubos ~ wrote, "Given enough time, a state of peaceful co-existence eventually becomes established between any host and parasite." Evolutionary biologists recognize a problem with this conclusion. Will the exploitative variant win or will it not? The answer depends on how negatively the level of disease affects transmission. At some point, the critical threshold will occur: the increased benefits to the disease organism associated with the additional increment in exploitation are counterbalanced by the increased cost associated with transmission. At that point, natural selection no longer acts to increase the disease organism's exploitation of the host. This tradeoff argument is the framework for much of modem theory about the evolution of virulence.
Note, however, that this tradeoff considers what is best for the pathogen. The host, on the other hand, would benefit from having no disease. Host and parasite, therefore, often are fated to a continual coevolutionary race, with the host evolving immunological attributes such as somatic mutation and alteration of major histocompatibility antigens to reduce the exploitation by the pathogen; the pathogen evolves countermeasures to break through this control and move it closer to its optimum. As the pathogen gets closer to its optimum, the evolutionary pressure for a still closer approach diminishes. Similarly, as the host gets closer to elimination of disease, the evolutionary pressure for further purging of negative effects diminishes. The expected host-parasite association, therefore, will be bounded between the host's favored situation of no disease and the optimum for the pathogen here portrayed.
This argument presumes that host exploitation and virulence are linked. Researchers who focus on the specific variants sometimes dismiss theoretical arguments about the evolution of virulence by noting that they can find virulent mutants that do not derive any benefit from their virulence. Their mistake is the failure to realize that these virulent mutants generally are found as laboratory artifacts. If a pathogen in nature imposes a fitness cost on itself without providing a compensating benefit, it will tend to be eliminated by natural selection. We expect, therefore, that competition in nature will allow high virulence only if it is linked to some evolutionary benefit, such as the propagative benefits generated from increased exploitation of hosts.
If this approach to the evolution of virulence is valid, it should direct us to categories of pathogens that would be driven by natural selection to high levels of host exploitation and hence to high levels of virulence. It is this kind of understanding that should help us identify those pathogens that represent the greatest emerging threat of maintaining themselves indefinitely in a damaging way.
I have already suggested that host immobilization may impose important costs on pathogens by inhibiting transmission. An ill host does not move around as much as a healthy host, and if the pathogen relies on that mobility for transmis-sion (as does, for example, the common cold virus), then the costs to the pathogen will rise relatively rapidly with increased host exploitation; consequently, natural selection should favor a relatively benign state of coexistence. But, some categories of disease organisms do not rely much on host mobility. Such organisms pay a relatively low price if their exploitation immobilizes the host. According to the tradeoff reasoning that I just have presented, pathogens in such categories should be particularly virulent. Some of these categories are discussed below.
TRANSMISSION BY ARTHROPOD VECTORS
One category involves transmission by arthropod vectors, such as mosquitoes.
If a disease organism is mosquito borne, then it still can be transmitted even if a person is immobilized entirely with illness because mosquitoes come to feed from the ill person. In fact, experimental studies indicate that mosquitoes are better able to bite a laboratory animal when it is sick with a vector-borne disease such as malaria than when it is healthy. As a consequence, natural selection should ratchet up the level of exploitation for vector-borne pathogens, and we should see particularly high virulence among vector-borne diseases.
One problem with testing this idea involves quantifying virulence. Many symptoms may be defensive for the host. The investigator must identify some characteristic that is an indicator of the harm being done to the host. I have chosen death. Unlike other symptoms of illness, death is rarely interpretable as a defense against the parasite. Using death as an indicator does not imply that death is beneficial to the parasite. Rather, it presumes only that probabilities of death are an indicator of harmfulness.
The mortality associated with untreated infections is highly variable for both vector-borne and directly transmitted pathogens, but it is greater for vector-borne pathogens than for directly transmitted pathogens. This difference is illustrated in Most pathogens of the respiratory tract fall into the mildest category: less than 1 death in 10,000 infections (the left-most category in Fig. 1 ). Yet, some, such as the smallpox virus and the tuberculosis bacterium, are regularly lethal.
If we are concerned about emerging disease organisms that are likely to be maintained stably with high virulence, obviously we cannot restrict our attention to vector-borne pathogens. We need to know why some pathogens of the human Therefore, data from vector-borne and respiratory tract pathogens of humans improve our ability to recognize pathogens that could be particularly dangerous once they have emerged. If a disease organism has just begun to emerge and it is durable or vector borne, it warrants special concern because it is in a category of organisms with a proven ability to maintain virulence over time. An emerging vector-borne disease may have the potential to be another malaria or yellow
fever. An emerging durable pathogen may have the potential to become another tuberculosis bacterium or smallpox virus. Such data are difficult to obtain, but a considerable amount of data were accu-mulated during the window of time between the first recognition of E. coli as a major cause of infantile diarrhea and the widespread use of effective antibiotics against it. These data from hospital outbreaks of E. coli show that, as the duration of outbreaks increased (beyond 15 months for some outbreaks), the deaths per infection increased (Fig. 2) .
If the increased lethality resulted from increased virulence, it is not critical whether the variation in virulence was generated de novo in the hospital environment or whether the harmful variants entered from the outside and were better able to persist in an environment with a great potential for attendant-borne transmission. Either way, the potential for attendant-borne transmission would have been responsible for increased virulence in the hospital environment. Data for other bacteria responsible for hospital outbreaks also are consistent with an association between attendant-borne transmission and increased virulence. 11"12
The data from hospital outbreaks suggest that, if we are concerned about the emergence of dangerous pathogens, we should pay close attention to hospital environments because particularly virulent variants may have a selective advantage in these environments. The concern is all the more pressing in light of the seemingly inexorable development of antibiotic resistance in hospital environments.
The evolutionary interpretation of the hospital data raises the possibility of controlling virulence by controlling its evolution. This evolutionary approach suggests that certain interventions will have greater long-term payoff relative to others than has previously been appreciated. Specifically, a greater investment in improving those hygienic standards that reduce attendant-borne transmission not only may reduce the frequencies of infection, but also may reduce the harmful- This hypothesized effect of waterborne transmission has been tested in a way analogous to the tests I have mentioned already. Specifically, I examined the literature to determine whether the lethality of bacterial agents of human diarrhea is correlated positively with the degree to which they are waterborne. Figure 3 shows that the correlation exists. Topping the list is the classical cholera organism, which in the absence of treatment, would kill approximately 15% of the people it infects. The agent of typhoid fever and the most severe of the agents of bacterial dysentery also often are waterborne and also are among the most-severe diarrheal pathogens.
CONCLUSION
None of the studies that I have presented is the final word. They represent a beginning rather than an end, the beginning of an ongoing synthesis of evolutionary biology with epidemiology and public health. The studies offer a collection If the answers are not available, they need to be obtained. We may need to invest our disease-control resources differently, to find out, for example, how durable a newly identified disease organism is in the external environment.
Although knowledge about pathogen characteristics is imperfect, the knowledge we have suggests that many of the disease organisms that capture our attention will be much less serious over the long run than others. Ebola virus, for example, has a mix of characteristics that are unlikely to allow it to persist stably with its characteristically high virulence in human populations (although we could use more information about its durability under various environmental conditions).
We can expect, instead, that it sporadically will cause nasty, but localized, outbreaks involving a few hundred people before burning itself out. The considerations raised here suggest that Rift Valley fever virus is overall a more dangerous pathogen. Being vector borne with sufficient virus density in the blood for humanmosquito-human transmission, it has a mix of characteristics that could allow it to persist stably in humans if the mosquito density is sufficient. If left unchecked, it poses a threat more like yellow fever than Ebola.
This presentation has focused on the usefulness of an evolutionary perspective for identifying pathogens that pose a particularly great threat to humans. Another, perhaps more important, evolutionary consideration asks whether this knowledge could enable us to prevent these organisms from becoming dangerous in the first place. I think it can.
Consider waterborne transmission. By introducing clean water supplies, we should be able to prevent those organisms that we have identified as waterborne 
